You seem to be using a cell phone.  To access the main menu, click on the compact button on the top left.  To reach the store, click here.  There is a compact login at the bottom of the page if you have difficulty logging in.

CABE Road Sign Final CABE's Moneco-Econtro Conference - August 27/28 - The Future Is Now: Catching up to digital realities in the Canadian economy

The CABE Salary Survey has been released, the first since 2010. Click here for a description.


For instructions on how to post job ads click here
The Canadian Association for Business Economics (CABE) is a professional association for those active in the field of business economics. CABE is a national organization with local chapters. Local and national events include luncheons, workshops and conferences.  For general information about CABE and its activities, contact CABE here.  Please leave a voice mail.  Chapter contacts are here.

Instructions for using the website are found here.  Social links are found below.  To subscribe to our various mailing lists, please visit this link.

CABE's Twitter Feed

The Economic Case for Universal Pharmacare

Dr. Steve Morgan

The World Health Organization has declared that all nations are obligated to ensure equitable access to necessary medicines through pharmaceutical policies that work in conjunction with broader systems of universal health coverage. To that end, every developed country with a universal health care system provides universal coverage of prescription drugs—except Canada.  Canadians deserve universal and equitable access to necessary medicines. Universal, comprehensive, public “Pharmacare”—working in conjunction with our universal “Medicare” system—is the best way to achieve this at a fair and affordable cost to patients and society as a whole.

Join Dr. Morgan in a webinar to discuss this key policy issue on September 21st at 1 p.m. Toronto Time.

Biographical Notes

Steve Morgan is a Professor of health policy in the School of Population and Public Health (UBC). An expert in pharmaceutical policy, Dr. Morgan’s research helps governments balance three sometimes-competing goals: providing equitable access to necessary medicines, managing health care spending responsibly, and providing incentive for valued innovation. Dr. Morgan has published over 100 peer-reviewed research papers on pharmaceutical policies. He has advised governments in Canada and abroad and has produced work for the World Health Organization and the Organization for Economic Cooperation and Development.

Dr. Morgan earned degrees in economics from the University of Western Ontario, Queen’s University, and the University of British Columbia. He received post-doctoral training in health care policy at McMaster University and UBC and numerous career awards.